Middle East Study of Infections in Patients With Hematological Malignancies (opens ClinicalTrials.gov)
- Sponsor
- Hamad Medical Corporation
- Enrolment
- 1,000
- Started
- 2024-09-15
- Last update
- 2026-10-30
Conditions: Hematological Malignancy, Hematopoetic Stem Cell Transplantation, Bloodstream Infection
Interventions: No Intervention: Observational Cohort